Xiaoling Wang
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
- Oncology 29
- Pancreatic and Hepatic Oncology Research 6
- Metal complexes synthesis and properties 5
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 4
-
- RNA modifications and cancer 4
- Co-authors
- Zhanjun Guo (4 shared papers)Ruixing Zhang (3 shared papers)Cui-ju Wang (3 shared papers)Zhong‐Lu You (5 shared papers)Baoen Shan (2 shared papers)Da‐Hua Shi (2 shared papers)Xiaofang Li (2 shared papers)Wenxue Chen (1 shared paper)
- Journals
- International Journal of Cancer (2 papers)Frontiers in Oncology (2 papers)Scientific Reports (1 paper)Nephron Experimental Nephrology (1 paper)European Journal of Cancer Prevention (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Xiaoling Wang
60 papers receiving 685 citations
Peers
Comparison fields: 5 of 99
- Geriatrics and Gerontology 44
- Cancer Research 130
- Oncology 232
- Molecular Biology 299
- Virology 18
Countries citing papers authored by Xiaoling Wang
This map shows the geographic impact of Xiaoling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wang more than expected).
Fields of papers citing papers by Xiaoling Wang
This network shows the impact of papers produced by Xiaoling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wang. The network helps show where Xiaoling Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 56 | |
| 2 | 2015 | 49 | |
| 3 | 2010 | 44 | |
| 4 | 2013 | 41 | |
| 5 | 2007 | 37 | |
| 6 | 2010 | 37 | |
| 7 | 2016 | 31 | |
| 8 | 2016 | 27 | |
| 9 | 2011 | 25 | |
| 10 | 2013 | 24 | |
| 11 | 2013 | 20 | |
| 12 | 2011 | 18 | |
| 13 | 2020 | 17 | |
| 14 | 2012 | 16 | |
| 15 | 2020 | 14 | |
| 16 | 2019 | 12 | |
| 17 | Younger age of onset and multiple primary lesions associated with esophageal squamous cell carcinoma cases with a positive family history of the cancer suggests genetic predisposition. | 2014 | 12 |
| 18 | 2011 | 12 | |
| 19 | 2022 | 11 | |
| 20 | 2022 | 11 |
About Xiaoling Wang
Xiaoling Wang is a scholar working on Oncology, Molecular Biology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 699 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Lung Cancer Treatments and Mutations (5 papers), Metal complexes synthesis and properties (5 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Mechanisms and Therapy (4 papers), RNA modifications and cancer (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Geriatrics and Gerontology (44 citations), Cancer Research (130 citations), Oncology (232 citations), Molecular Biology (299 citations) and Virology (18 citations). Xiaoling Wang has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Zhanjun Guo, Ruixing Zhang, Cui-ju Wang, Zhong‐Lu You, Baoen Shan, Da‐Hua Shi, Xiaofang Li, Wenxue Chen, Ping Wang and Xiaohua Wu. Their work appears in journals such as International Journal of Cancer, Frontiers in Oncology, Scientific Reports, Nephron Experimental Nephrology and European Journal of Cancer Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.